Copyright
©The Author(s) 2019.
World J Psychiatr. Jun 10, 2019; 9(3): 47-54
Published online Jun 10, 2019. doi: 10.5498/wjp.v9.i3.47
Published online Jun 10, 2019. doi: 10.5498/wjp.v9.i3.47
Table 1 Quality of studies reviewed
| Name of publication of study | Yr | Random-ization? | Similar groups initially? | Equal treatments? | All participants accounted for? | Analyzed in groups to which they were randomized? | Objective/“blind” treatments? | Overall quality of the study |
| Meltzer et al[23] | 2010 | Yes | Yes | Yes | Yes | Yes | Yes | Good |
| Cummings et al[24] | 2014 | Yes | Yes | Yes | Yes | Yes | Yes | Good |
- Citation: Tampi RR, Tampi DJ, Young JJ, Balachandran S, Hoq RA, Manikkara G. Evidence for using pimavanserin for the treatment of Parkinson's disease psychosis. World J Psychiatr 2019; 9(3): 47-54
- URL: https://www.wjgnet.com/2220-3206/full/v9/i3/47.htm
- DOI: https://dx.doi.org/10.5498/wjp.v9.i3.47